Ikarian Capital, LLC - 31 Dec 2025 SCHEDULE 13G Report for Kazia Therapeutics Limited American Depositary Shares, each representing five-hundred Ordinary Shares (KZIA)

Filing Manager
Ikarian Capital, LLC
Reporting Manager
Ikarian Capital, LLC
Security
Kazia Therapeutics Limited American Depositary Shares, each representing five-hundred Ordinary Shares
Symbol
KZIA
Shares outstanding
11,387,333 shares
Disclosed Ownership
580,754 shares
Ownership
5.1%
Form type
SCHEDULE 13G
Filing time
17 Feb 2026, 17:47:40 UTC
Date of event
31 Dec 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Ikarian Capital, LLC disclosed 5.1% ownership in Kazia Therapeutics Limited American Depositary Shares, each representing five-hundred Ordinary Shares (KZIA) on 31 Dec 2025."

Quick Takeaways

  • Ikarian Capital, LLC filed SCHEDULE 13G for Kazia Therapeutics Limited American Depositary Shares, each representing five-hundred Ordinary Shares (KZIA).
  • Disclosed ownership: 5.1%.
  • Date of event: 31 Dec 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 17 Feb 2026, 17:47.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Ikarian Capital, LLC 5.1% 580,754 0 580,754 /s/ Neil Shahrestani Neil Shahrestani, Sole Manager
Neil Shahrestani 5.1% 580,754 0 580,754 /s/ Neil Shahrestani Neil Shahrestani

Sponsored